Cited by 69Sphingolipid Metabolism and SignalingCancer, Lipids, and MetabolismLysosomal Storage Disorders Research

De novo N-palmitoylsphingosine synthesis is the major biochemical mechanism of ceramide accumulation following p53 up-regulation

Panjarian, Shoghag, Kozhaya, Lina, Arayssi, Sawsan, Yehia, Maisaa, Bielawski, Jacek, Bielawska, Alicja, Usta, Julnar, Hannun, Yusuf A. +2 more·2008·Prostaglandins & Other Lipid Mediators

Abstract

The tumor suppressor protein p53 and the putative lipid tumor suppressor ceramide play pivotal roles in inducing cell cycle arrest or in driving the cell towards apoptosis. Previously we had shown that, in a p53-dependent model of cell death, ceramide accumulated in a p53-dependent manner [Dbaibo GS, Pushkareva MY, Rachid RA, Alter N, Smyth MJ, Obeid LM, Hannun YA. J Clin Invest 1998;102:329-339]. In the current study, we investigated the biochemical pathways by which ceramide accumulated following p53 up-regulation. In both Molt-4 LXSN leukemia cells exposed to gamma-irradiation and in EB-1 colon cancer cells treated with ZnCl(2), p53 up-regulation led to de novo ceramide synthesis with predominance of N-palmitoylsphingosine (C16-ceramide) synthesis. The activation of the de novo pathway was not associated with increased activity of the key enzyme serine palmitoyltransferase (SPT) but rather with the increased activity of ceramide synthase. Furthermore, transcriptional up-regulation of the palmitoyl-specific Lass5 ceramide synthase gene was observed in Molt-4 but not in EB-1 cells. The SPT inhibitor ISP-1 or the ceramide synthase inhibitor fumonisin B1 led to substantial inhibition of ceramide accumulation in response to p53 up-regulation. Other biochemical pathways of ceramide generation such as sphingomyelinase activation were examined and found unlikely to contribute to p53-dependent ceramide formation. These studies indicate that p53 specifically drives de novo ceramide synthesis by activation of a ceramide synthase that favors the synthesis of N-palmitoylsphingosine.

Integrity signals

Registry

Crossref · 10.1016/j.prostaglandins.2008.02.004

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Apoptosis can be activated by ceramide, and p53 appears to directly upregulate the ceramide synthase-encoding genes CERS5 and CERS6 and to induce ceramide production.

    “Apoptosis also can be activated by ceramide,186 and p53 appears to directly upregulate the ceramide synthase-encoding genes CERS5 (Table 1) and CERS6187 and to induce ceramide production.188”

    From Census and evaluation of p53 target genes (2017) · cites this paper as [188]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Panjarian, S., Kozhaya, L., Arayssi, S., Yehia, M., Bielawski, J., Bielawska, A., Usta, J., Hannun, Y. A., Obeid, L. M., & Dbaibo, G. S.
Affiliations
  • American University of Beirut (LB)
  • Medical University of South Carolina (US)
Corresponding author
Dbaibo, Ghassan S.
Venue
Prostaglandins & Other Lipid Mediators
Publisher
Elsevier BV
Published
2008-06
Volume
86
Issue
1-4
Pages
41-48
ISSN
1098-8823 (ISSN-L)
OpenAlex
W2146193904
Cited by
69
References
52
Citations by year
2026: 2 · 2025: 5 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 3 · 2018: 7 · 2017: 3 · 2016: 2 · 2015: 3 · 2014: 5 · 2013: 2 · 2012: 5
FWCI
2.75
Type
journal article
Language
en
Open access
closed
Locations
  • Prostaglandins & Other Lipid Mediators (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American University of Beirut
  • National Science Foundation (USA 0090859)
  • National Institutes of Health (AG16583)
  • U.S. Department of Veterans Affairs
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
  • Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
Keywords
p53, ceramide accumulation, de novo ceramide synthesis, ceramide synthase, serine palmitoyltransferase, isp-1, fumonisin B1, sphingomyelinase, apoptosis, gamma irradiation, zinc chloride, MOLT-4 cells, transcriptional upregulation
MeSH terms
Ceramides, Chlorides, Enzyme Activation, Gamma Rays, Humans, Oxidoreductases, Sphingomyelin Phosphodiesterase, Up-Regulation, Tumor Suppressor Protein p53, Zinc Compounds, Reverse Transcriptase Polymerase Chain Reaction, Spectrometry, Mass, Electrospray Ionization, Cell Line, Tumor, Serine C-Palmitoyltransferase, Tandem Mass Spectrometry

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review